NTC grants to Zhaoke exclusive license and distribution rights in [...] | Comunicati stampa CataniaOggi
14 gennaio 2021 11:08 Fonte: Adnkronos #salute-e-benessere MILAN, Italy and HONG KONG, Jan. 14, 2021 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered in Italy, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, having a fully integrated ophthalmic platform with strong foundation in eyecare, announce today their agreement for exclusive license and distribution rights of NTC014, innovative fixed combination of a quinolone antibiotic and a NSAID in eye drops. Zhaoke will market NTC014 in the People's Republic of China, Hong Kong, Macau, Taiwan, AS...